Navigation Links
BioFortis Wins Best Product Award in Discovery Informatics at the 2009 Molecular Medicine Tri-Conference
Date:3/5/2009

Biomedical Informatics Market Leader BioFortis wins another award for its Labmatrix(TM) platform being used by leading pharmaceutical and institutional clients worldwide for translational research, biomarker discovery, biobanking, and clinical research

COLUMBIA, Md., March 5 /PRNewswire/ -- BioFortis, Inc., the leading provider of biomedical informatics solutions used by pharmaceutical and institutional clients, today announced it has won the 2009 Molecular Medicine Tri-Conference "Best Product Award" for its leading Labmatrix(TM) platform. The award is given to the best peer-reviewed solution at the annual conference.

The Best Product Award honored companies that launched the best products at the 2009 Molecular Medicine Tri-Conference. Approximately 2600 attendees of the conference were invited to vote on the contestants' products and the winners were announced at a special ceremony.

Labmatrix(TM) was designed as a solution to enable a comprehensive "bench-to-bedside" approach to the study of human diseases, while permitting collaboration in a secure environment that facilitates regulatory compliance. Labmatrix(TM) provides a clear competitive advantage for organizations that must keep pace in an era of new, high-throughput technologies utilized in discovery programs focused on next-generation therapeutics. BioFortis is the leader in information management for translational research, biomarker discovery, biobanking and clinical research, supporting multiple pharmaceutical clients and research institutions in their mission of speeding drug discovery and driving personalized medicine into practice.

"We are thrilled to win this award," said Jian Wang, BioFortis CEO, "especially considering it is an award voted on by researchers directly. This validates our mission to create data management and exploration tools that are so easy scientists can use effectively from day one. This award reaffirms our leadership position in providing informatics solutions for translational and biomarker researchers."

About BioFortis

BioFortis is a leading provider of biomedical informatics solutions. Our lead product, Labmatrix(TM), addresses research needs of the post-genomic era within several key application areas including translational research, biobanking, biomarker discovery and clinical research. Labmatrix(TM) is a web-based software application for the management and exploration of clinical, specimen and molecular assay data. With the ability to integrate these data sets in a tightly linked, highly annotated manner, Labmatrix(TM) is being used by customers in the biopharmaceutical industry, academia and government research institutions.

BioFortis and Labmatrix(TM) are registered trademarks of BioFortis, Inc.

www.biofortis.com


'/>"/>
SOURCE BioFortis, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. House Committee Vote Sets Congress on Course for Historic Regulation of Tobacco Products
2. On March 4, 2009, The United States Supreme Court Rejected the Rationale Behind Michigans Drug Product Liability Law
3. MedX Health Receives CE Mark for Laser & Light Products
4. a la mode Bra Fitting Specialty Boutique Now Has Trained Fitters and Products for Women Who Are Post Op Mastectomy or Lumpectomy
5. Johnson Institute Transfers Key Programs and Products to Hazelden Foundation
6. Congress Can Deliver Historic Victory for Children and Americas Health By Granting FDA Authority Over Tobacco Products
7. Best New Product Awards Winners Named at Molecular Medicine Tri-Conference
8. Halo Pharmaceutical Launches a Branded Product Marketing Company in Canada
9. Prudential Long-Term Care Product Simplifies Decisions
10. Natural Products Association Comments on New GAO Report on Regulation of Dietary Supplements
11. Thermogenesis Technology Products Surpass Processing of More Than One Million Units of Cord Blood Stem Cells at 10-Year Milestone
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... June 27, 2016 , ... TopConsumerReviews.com recently awarded their highest five-star rating to ... of individuals in the United States and Canada wear eyeglasses. Once considered to be ... vision and make a fashion statement. Even celebrities use glasses as a way of ...
(Date:6/26/2016)... ... , ... On June 10-11, 2016, A Forever Recovery, a holistic treatment center ... Breakfast Table in Battle Creek, MI, where the rehabilitation facility is located. This annual ... the world’s leading providers of cereal and other breakfast foods. Its residents often refer ...
(Date:6/26/2016)... ... 26, 2016 , ... PawPaws brand pet supplements owned by Whole ... enhance the health of felines. The formula is all-natural and is made from Chinese ... PawPaws Cat Kidney Support Supplement Soft Chews are Astragalus Root Extract and ...
(Date:6/26/2016)... ... June 26, 2016 , ... Many women are confused ... endometriosis. These women need a treatment plan to not only alleviate symptoms and ... help for preservation of fertility and ultimately achieving a pregnancy. The specialists at ...
(Date:6/25/2016)... ... ... Austin residents seeking Mohs surgery services, can now turn to Dr. Jessica ... Peckham for medical and surgical dermatology. , Dr. Dorsey brings specialization to include Mohs ... Mohs Micrographic Surgery completed by Dr. Dorsey was under the direction of Glenn Goldstein, ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016  Global Blood Therapeutics, ... company developing novel therapeutics for the treatment of ... announced the closing of its previously announced underwritten ... at the public offering price of $18.75 per ... were offered by GBT. GBT estimates net proceeds ...
(Date:6/24/2016)... DUBLIN , June 24, 2016 ... and Markets has announced the addition of the ... their offering. ... products and provides an updated review, including its applications ... covering the total market, which includes three main industries: ...
(Date:6/24/2016)... -- The Academy of Managed Care Pharmacy (AMCP) today ... allow biopharmaceutical companies to more easily share health care ... coverage decisions, a move that addresses the growing need ... The recommendations address restrictions in the sharing of product ... a prohibition that hinders decision makers from accessing HCEI ...
Breaking Medicine Technology: